
Pharmacally
DARZALEX
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in DARZALEX
Health TidingsDARZALEX Powers Past Expectations with $3.96 Billion Q1 Sales SurgeGlobal Q1 2026 sales of DARZALEX reached USD 3.96 billion, with strong U.S. performance and growing adoption of the subcutaneous DARZALEX FASPRO supporting continued royalty revenue for Genmab.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.